Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.8.0
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 19244231
Yoon YS, et al. (2009) Salt-inducible kinase regulates hepatic lipogenesis by controlling SREBP-1c phosphorylation. J Biol Chem 284, 10446-52 19244231
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

S265-p - SREBP-1 iso4 (mouse)
Modsite: AIEKRYRssINDKIV SwissProt Entrez-Gene
Orthologous residues
SREBP‑1 (human): S337‑p, SREBP‑1 iso3 (human): S313‑p, SREBP‑1 iso4 (human): S367‑p, SREBP‑1 (mouse): S331‑p, SREBP‑1 iso4 (mouse): S265‑p, SREBP‑1 (rat): S331‑p, SREBP‑1 iso1 (rat): S307‑p
Characterization
Methods used to characterize site in vivo mutation of modification site, western blotting
Disease tissue studied:  liver cancer
Relevant cell lines - cell types - tissues:  HepG2 (hepatic)
Cellular systems studied:  cell lines
Species studied:  human
Downstream Regulation
Effect of modification (function):  molecular association, regulation
Effect of modification (process):  transcription, altered
Modification regulates interactions with: 
Interacting molecule Interacting domains Effect Consequences (function) Consequences (process) Detection assays
Disrupts
Comments:  regulates hepatic lipogenesis

S266-p - SREBP-1 iso4 (mouse)
Modsite: IEKRYRssINDKIVE SwissProt Entrez-Gene
Orthologous residues
SREBP‑1 (human): S338‑p, SREBP‑1 iso3 (human): S314‑p, SREBP‑1 iso4 (human): S368‑p, SREBP‑1 (mouse): S332‑p, SREBP‑1 iso4 (mouse): S266‑p, SREBP‑1 (rat): S332‑p, SREBP‑1 iso1 (rat): S308‑p
Characterization
Methods used to characterize site in vivo mutation of modification site, western blotting
Disease tissue studied:  liver cancer
Relevant cell lines - cell types - tissues:  HepG2 (hepatic)
Cellular systems studied:  cell lines
Species studied:  human
Downstream Regulation
Effect of modification (function):  molecular association, regulation
Effect of modification (process):  transcription, altered
Modification regulates interactions with: 
Interacting molecule Interacting domains Effect Consequences (function) Consequences (process) Detection assays
Disrupts
Comments:  regulates hepatic lipogenesis

S329-p - SREBP-1 iso4 (mouse)
Modsite: KSLKDLVsACGSGGG SwissProt Entrez-Gene
Orthologous residues
SREBP‑1 (human): S402‑p, SREBP‑1 iso3 (human): S378‑p, SREBP‑1 iso4 (human): S432‑p, SREBP‑1 (mouse): S395‑p, SREBP‑1 iso4 (mouse): S329‑p, SREBP‑1 (rat): S395‑p, SREBP‑1 iso1 (rat): S371‑p
Characterization
Methods used to characterize site in vivo mutation of modification site, western blotting
Disease tissue studied:  liver cancer
Relevant cell lines - cell types - tissues:  HepG2 (hepatic)
Cellular systems studied:  cell lines
Species studied:  human
Enzymes shown to modify site in vitro
Type Enzyme
KINASE SIK (human)
Downstream Regulation
Effect of modification (function):  activity, inhibited, molecular association, regulation
Effect of modification (process):  transcription, altered
Modification regulates interactions with: 
Interacting molecule Interacting domains Effect Consequences (function) Consequences (process) Detection assays
Disrupts
Comments:  regulates hepatic lipogenesis